Auditory Health Considerations During the COVID-19 Pandemic
While the primary symptoms of COVID-19 are respiratory in nature, clinical observations have increasingly identified neurological manifestations associated with the virus. Research published in JAMA Neurology indicates that approximately 36.4 percent of hospitalized patients experienced neurological symptoms affecting the central nervous system, peripheral nervous system, and skeletal muscles. Furthermore, emerging evidence suggests that the virus may potentially impact the auditory organs of the inner ear.
Tinnitus and the Impact of Psychological Stress
Although direct clinical links between the novel coronavirus and tinnitus are still being investigated, the American Tinnitus Association (ATA) has highlighted the role of psychological factors in exacerbating auditory symptoms. The stress, anxiety, and depression associated with social isolation and the ongoing risk of infection can increase the likelihood of individuals experiencing tinnitus.
Large-scale population studies have shown that individuals with generalized anxiety disorder are significantly more likely to experience chronic and burdensome tinnitus. Given the current global climate of heightened vigilance and social distancing, managing mental well-being is a critical component of maintaining overall auditory health.
Ototoxicity and Potential Treatment Risks
Ototoxicity—the property of being toxic to the ear—is a recognized cause of hearing loss. While it is premature to determine the ototoxic risk of potential vaccines, some pharmacological treatments discussed in the context of COVID-19 do pose potential risks to the auditory system:
•Quinine-Based Medications: Historically used for malaria, some drugs in this family have a known history of ototoxicity. However, hydroxychloroquine, which has been studied for COVID-19 treatment, is generally associated with a lower risk of auditory side effects compared to other quinine derivatives.
•Antiviral Therapeutics: Remdesivir, a prominent antiviral used in clinical settings, does not currently list ototoxicity as a potential side effect according to its manufacturer, Gilead Sciences, Inc.
Safe Delivery of Essential Hearing Healthcare
During periods of public health concern, maintaining hearing health is more critical than ever for staying informed and connected. Hearing healthcare professionals have implemented rigorous safety protocols to ensure that essential services can be delivered while minimizing the risk of transmission. These measures include:
•Telehealth Services: Utilizing remote consultations to provide care without the need for in-person visits.
•Enhanced PPE and Office Protocols: Rigorous use of personal protective equipment and sanitized in-office procedures.
•Curbside Assistance: Offering contactless service for hearing aid maintenance and repairs.
By adopting these best practices, clinicians can continue to provide vital auditory care while effectively mitigating health risks for both patients and staff. Schedule a professional hearing consultation today to receive a comprehensive evaluation and learn more about how Starkey’s hearing solutions can support your wellness in any environment. Discover the benefits of modern hearing technology and how it can help you stay connected and healthy.
Sources:
•“Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.” JAMA Neurology.
•“Understanding the Facts.” American Tinnitus Association.
•Seçkin U, et al. “Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis.” Rheumatol Int. 2000.